pharmaphorum

JULY 27, 2021

Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. per share in the initial deal, which will give it a 64.6% stake in the company.

Drug Delivery 111

Drug Delivery Insulin Cosmetics Development 111

Roots Analysis

SEPTEMBER 18, 2023

Therefore, medical technology is rapidly evolving, enabling more advanced and patient-friendly methods of drug delivery. In the pursuit of creating patient-centric healthcare solutions, the medical industry has witnessed a groundbreaking advancement in drug delivery with the emergence of large volume wearable injectors.

Drug Delivery 52

Drug Delivery Drugs Compliance Marketing 52

Roots Analysis

FEBRUARY 22, 2022

Autoinjector As Emerging Drug Delivery Device. One of the most widely recognized autoinjector in the market is EpiPen® (Mylan), which is a prefilled epinephrine autoinjector. The market landscape is predominantly characterized by the presence of several small and mid-sized companies with a few established players.

Drug Delivery 52

Drug Delivery Production Marketing Development 52

pharmaphorum

MAY 21, 2021

In SURPASS-4 – the last of Lilly’s registration studies for the dual GLP-1/GIP agonist – tirzepatide met all its primary and secondary objectives, besting treatment with insulin glargine, a long-acting human insulin product that is a mainstay of diabetes treatment, in diabetics with increased cardiovascular risk. Arecor alliance.

Trials 52

Trials Insulin Sales Drug Delivery 52

FDA Law Blog

JANUARY 5, 2023

The current Team Lead for Injection Devices in CDRH’s Division of Drug Delivery and General Hospital Devices and Human Factors noted that depending on the product, the pre-market path for a connected combination product might require an IND, IDE, or a determination that it is a medical device data system , which are not regulated as devices.

Regulation 59

Regulation Production Drug Delivery Marketing 59

pharmaphorum

FEBRUARY 3, 2022

There is a rising demand for vaccines, insulin, and many modern medicines used to treat cancer and other chronic diseases. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years.

Drug Delivery 52

Drug Delivery Drugs Engineer Scientist 52

pharmaphorum

JANUARY 12, 2023

Oramed Pharma has conceded defeat in its attempt to bring an oral formulation of insulin to market for people with type 2 diabetes, after its ORMD-0801 candidate missed the mark in a phase 3 trial. The post Phase 3 trial dashes Oramed’s oral insulin hopes appeared first on.

Insulin 59

Insulin Trials Development Drugs 59

Roots Analysis

MARCH 21, 2022

However, several drug delivery devices that enable patients to self-administer their respective medications are now available. Subcutaneous biologics – current market landscape. Subcutaneous drug delivery systems – the helping hand for patients. Of these, 50 players have approved subcutaneous biologics.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Antibody Drugs 52

Roots Analysis

SEPTEMBER 22, 2023

These innovative instruments combine precision, convenience, and patient-centered design to revolutionize drug delivery. These significant benefits offered by wearable injectors, coupled with their rising demand in the pharmaceutical industry and healthcare sector, worldwide is likely to drive market growth during in the coming years.

Drug Delivery 40

Drug Delivery Marketing Insulin Drugs 40

pharmaphorum

JUNE 10, 2021

The fundamental misconception among the public, the media and even some lawmakers is that higher drug list prices are the result of drug manufacturers being in a monopolistic position to endlessly raise prices on critical drugs like insulin and then rake in big profits.

Manufacturing 105

Manufacturing Drugs Pharma Companies Pharmacy 105

XTalks

JANUARY 23, 2025

PBMs serve as intermediaries between insurers, pharmacies and drug manufacturers, negotiating discounts and managing drug formularies. While PBMs were originally intended to lower costs and streamline drug delivery, critics argue that their practices often lead to inflated prices and restricted access for consumers.

Drugs 59

Drugs Generic Drugs Pharmacy Insulin 59